ENTITY
Mylan NV

Mylan NV (MYL US)

57
Analysis
Health Care • United States
Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
more
bearish•Mylan NV
•15 Dec 2016 21:35

Indictments Starting to Appear

The US Department of Justice (DOJ) filed charges (attached) against two former senior executives of Heritage Pharmaceuticals, a subsidiary of Pune,...

Share
bearish•Laurus Labs
•05 Dec 2016 03:49

Laurus Labs: Final Thoughts

The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...

Share
bullish•Laurus Labs
•25 Nov 2016 04:24

Laurus Labs IPO Overview

India-based Laurus Labs has filed for a listing on the BSE and NSE, and reportedly plans to raise up to Rs300 crore for debt repayment and general...

Share
bearish•Mylan NV
•18 Nov 2016 11:54

No Trump Cards for This Risk

This Insight is an update from Generic Drug Antitrust Inquiry: A Primer. Several generic drug companies caught up in government investigations into...

Share
bearish•Mylan NV
•14 Nov 2016 11:55

Generic Drug Antitrust Inquiry: A Primer

Recent news stories reporting looming criminal antitrust charges against certain generic drug companies (and possibly executives) are wighing on...

Share
x